Facebook
Twitter
LinkedIn
Forward
Multiple Sclerosis and Autoimmune Neurology Update (in cooperation with the National Multiple Sclerosis Society – Arizona Chapter) 2017 General Session
Course Directors: Jonathan L. Carter, M.D.,Dean M. Wingerchuk, M.D.
This state-of-the-art update on Multiple Sclerosis and Autoimmune Neurology is designed to provide evidence-based strategies that focus on practical clinical management from a multidisciplinary approach when treating patients with these neurologic disorders.
The format will include the latest clinical and laboratory research presented through didactic lecture, case vignettes, interactive Q & A sessions, and the opportunity for open discussions with the faculty.
Attendees are encouraged to submit case vignettes for review and discussion by the panel members. Send your submissions to: mca.cme@mayo.edu and add a subject line with “MS 2017 Case”.
NEW THIS YEAR!
If you are unable to attend the conference in-person, you will have the option to participate via a LIVE webcast.
Registration Fee
| Register on or before January 10 | Register after January 10 | |
| Full Fee: M.D., D.O., Scientist | $420.00 | $495.00 |
| Reduced Fee: Resident, Fellow, NP, PA, Allied Health Professional, Retiree | $220.00 | $295.00 |
| Webcast | $375.00 | $375.00 |
ATTENTION: Please login or create an account to unlock and register at the bottom of this page.
Additional Information
Lodging and Accommodations
Course Schedule
Course Faculty
Course Credit
Course Postcard
Exhibit Opportunity
This course offers the unique opportunity for commercial companies to interact with health care providers and highlight their products and services. If you are interested in exhibiting at this course, please complete the attached exhibit forms and submit to Kristy Badder.
Target Audience
This course is designed to update the entire multidisciplinary team, including neurologists, primary care physicians, nurse practitioners, physician assistants, nurses, physical therapists, occupational therapists and all heath care providers who treat patient with neurologic disorders.
Learning Objectives
Upon conclusion of this program, participants should be able to:
- Cite the mechanism of action, indications, and adverse events associated with recently-approved MS and autoimmune neurology disease-modifying therapies.
- Identify which patient would be a candidate to try these new disease-modifying therapies or to switch from an existing one.
- Implement safety guidelines in applying new disease-modifying therapies concurrently with other types of treatment.
- Describe appropriate management of common MS symptoms.
Attendance at this Mayo course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.
Contact us
Phone: (480) 301-4580
E-mail: mca.cme@mayo.edu
Available Credit
- 10.25 AAFP Prescribed
- 11.00 AMA PRA Category 1 Credit™
- 10.75 AOA